Top Employer-Paid Stories
New treatments for people with a rare form of heart failure are in the pipeline
By Andy SzczotkaFor employers' health plans, the new ATTR-CM specialty drugs could cost $500,000 per participant treated.
The latest regulatory issues, trends and best practices in providing employer-paid benefits such as health insurance, 401(k) and retirement planning.
For employers' health plans, the new ATTR-CM specialty drugs could cost $500,000 per participant treated.